|
Guidance Asks for Tests to Establish Validity of Highly Multiplexed IVDs
Clinical validation of highly multiplexed microbiological/medical countermeasure in vitro nucleic acid-based diagnostic devices (HMMDs) should include a limited prospective, randomized study of patients with symptoms of the infection the device is intended to identify.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives